News About: Pharm. Industry
Ahngook wins Norvasc patent suit
Ahngook Pharm got more good news on September 24, as the company said the Supreme Court upheld the company's Korean patent covering the active ingredient in Norvasc, the world's most-prescribed branded medicine for tr...
4 original drugs prices to fall by 20%
The four original drugs, including Lilly’s Zyprexa, Novo Nordisc’s Norditropin SimpleXx and Sanofi Aventis’ Taxotere will be decreased by 20 percent, when their patents are to be expired and corresponding generic drug...
DTC advertising plan of prescription drugs hits snag
The Ministry of Strategy and Finance has hit a snag with its plan to allow drug makers to advertise prescription drugs at mass media aimed at boosting the local service industry, with most of related parties, includin...
Hospira opens Korean branch
The US based Hopira, Inc., global pharmaceutical and drug delivery company, is looking to take a firm presence in the domestic market by setting up its Korean unit.
Tim Oldham, president of Hopira’s Asia-Pacific Bu...
Court ruling to be made available in October
Seoul Central District Court will make its final ruling on redemption suit of medication costs against Yungjin Pharm and Ildong Pharm on October 14.
The court is now in process of reviewing the documents submitted ...
FTC to monitor illegal rebate
The Fair Trade Commission (FTC) said on September 23 that the business regulator will make endeavors to allow a culture of fair trade to take root, citing some types of unfair practices such as price fixing, illicit i...
MSD Korea, CJ to co-market Singulair
CJ Cheil Jedang and MSD Korea announced on September 22 that the two companies have signed an agreement to co-market Singulair (montelukast sodium) in Korea.
Singulair is indicated for the prophylaxis and chronic ...
LG Life Sciences to conduct Phase 3 clinical trials over new diabetes treatment
LG Life Sciences (LGLS), a Korean pharmaceutical manufacturer, said on September 22 that it will begin Phase III clinical trials for LC15-0444, a new anti-diabetic agent, in Korea and India.
LC15-0444, a dipeptidyl...
Green Cross joins WHO-led flu vaccine bidding
Green Cross Corporation said on September 22 that it has a large bid for a World Health Organization (WHO) program to provide 400 million doses of Influenza A (H1N1) flu vaccine to South America.
The company has su...
Choong-wae shares boosted by new anticancer agent
Shares of Choong-wae Pharm, a leading pharmaceutical firm, were boosted on September 21 by expectations that the company recently won the US patent of new anticancer agent and this may help lift earnings in the years ...
